This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Aelis Farma, Universitë De Bordeaux. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 226 
Years Active: 2026
Title: Andrés Ozaita - Innovator in Cognitive Disorder Treatments
Introduction
Andrés Ozaita is an inventor based in Barcelona, Spain. He has made significant contributions to the field of cognitive disorders through his research and patent applications. Although he currently holds no granted patents, his work is noteworthy for its potential impact on treatment options.
Latest Patent Applications
Andrés Ozaita has filed a patent application for a compound known as 3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one. This compound is intended for use in the treatment of cognitive disorders. The invention relates to a specific pregnenolone derivative that has shown in vivo potency in correcting cognitive impairments associated with these disorders. The application highlights the potential of this compound to provide new avenues for treatment.
Conclusion
Andrés Ozaita's innovative work in the realm of cognitive disorders showcases his dedication to advancing medical science. His research may pave the way for future breakthroughs in treatment options for cognitive impairments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile